Trials
ClinicalTrials.gov
Search clinical trials by condition, drug, outcome or NCT number, with the results each one posted.
193,990 genes from NCBI Gene. Counted 2026-11-11.
Most papers first61 to 80 of 193,990
| Gene | NCBI Gene | Proteins | Patents | Drugs | Trials | NIH grants | Papers |
|---|---|---|---|---|---|---|---|
| ANXA5 annexin A5 | 308 HGNC:543 | 1 | 176 | 0 | 0 | 18,612 | 72,033 |
| MAPK8 mitogen-activated protein kinase 8 | 5599 HGNC:6881 | 1 | 80 | 3 | 4 | 22,304 | 72,009 |
| CCND1 cyclin D1 | 595 HGNC:1582 | 1 | 160 | 3 | 313 | 16,784 | 71,721 |
| EREG epiregulin | 2069 HGNC:3443 | 1 | 98 | 1 | 5 | 20,542 | 70,888 |
| BRAF B-Raf proto-oncogene, serine/threonine kinase | 673 HGNC:1097 | 1 | 210 | 20 | 1,261 | 13,360 | 68,535 |
| IGHE immunoglobulin heavy constant epsilon | 3497 HGNC:5522 | 1 | 3 | 6 | 160 | 10,057 | 68,531 |
| IL12B interleukin 12B | 3593 HGNC:5970 | 1 | 645 | 11 | 380 | 20,833 | 67,481 |
| KRT20 keratin 20 | 54474 HGNC:20412 | 1 | 25 | 0 | 0 | 13,166 | 66,736 |
| CDKN2A cyclin dependent kinase inhibitor 2A | 1029 HGNC:1787 | 2 | 229 | 0 | 0 | 17,828 | 66,498 |
| GPT glutamic--pyruvic transaminase | 2875 HGNC:4552 | 1 | 44 | 0 | 0 | 8,705 | 66,115 |
| CSF2 colony stimulating factor 2 | 1437 HGNC:2434 | 1 | 718 | 6 | 42 | 22,649 | 65,745 |
| PIK3R1 phosphoinositide-3-kinase regulatory subunit 1 | 5295 HGNC:8979 | 1 | 103 | 28 | 203 | 23,190 | 65,600 |
| BRCA1 BRCA1 DNA repair associated | 672 HGNC:1100 | 1 | 186 | 0 | 0 | 16,208 | 65,310 |
| HLA-C major histocompatibility complex, class I, C | 3107 HGNC:4933 | 1 | 78 | 0 | 0 | 24,228 | 65,190 |
| TENM1 teneurin transmembrane protein 1 | 10178 HGNC:8117 | 1 | 26 | 0 | 0 | 4,525 | 65,045 |
| LEP leptin | 3952 HGNC:6553 | 1 | 280 | 0 | 0 | 17,551 | 64,915 |
| SOD1 superoxide dismutase 1 | 6647 HGNC:11179 | 1 | 212 | 1 | 6 | 12,896 | 64,392 |
| APOE apolipoprotein E | 348 HGNC:613 | 1 | 264 | 0 | 0 | 22,367 | 64,067 |
| CD19 CD19 molecule | 930 HGNC:1633 | 1 | 328 | 17 | 388 | 20,342 | 63,419 |
| MMP2 matrix metallopeptidase 2 | 4313 HGNC:7166 | 1 | 136 | 3 | 13 | 13,695 | 62,233 |
Response
The first 2 of this page's 20 results. GET /api/genes/v1?page=4
{
"data": {
"total": 193990,
"results": [
{
"id": "308",
"title": "ANXA5: annexin A5",
"summary": "NCBI Gene 308. 1 protein, 176 patents, 0 drugs, 0 trials, 18,612 NIH grants and 72,033 papers.",
"record": "/library/genes/308",
"gene_id": 308,
"symbol": "ANXA5",
"name": "annexin A5",
"hgnc_id": "HGNC:543",
"counts": {
"proteins": 1,
"patents": 176,
"drugs": 0,
"trials": 0,
"grants": 18612,
"papers": 72033
}
},
{
"id": "5599",
"title": "MAPK8: mitogen-activated protein kinase 8",
"summary": "NCBI Gene 5599. 1 protein, 80 patents, 3 drugs, 4 trials, 22,304 NIH grants and 72,009 papers.",
"record": "/library/genes/5599",
"gene_id": 5599,
"symbol": "MAPK8",
"name": "mitogen-activated protein kinase 8",
"hgnc_id": "HGNC:6881",
"counts": {
"proteins": 1,
"patents": 80,
"drugs": 3,
"trials": 4,
"grants": 22304,
"papers": 72009
}
}
],
"columns": [
{
"key": "symbol",
"label": "Gene",
"under": "name"
},
{
"key": "id",
"label": "NCBI Gene",
"under": "hgnc_id"
},
{
"key": "counts.proteins",
"label": "Proteins"
},
{
"key": "counts.patents",
"label": "Patents"
},
{
"key": "counts.drugs",
"label": "Drugs"
},
{
"key": "counts.trials",
"label": "Trials"
},
{
"key": "counts.grants",
"label": "NIH grants"
},
{
"key": "counts.papers",
"label": "Papers"
}
],
"order": "Most papers first"
},
"release": "gene-search-2026-11-11-0.1.0",
"terms": [
{
"source": "ClinicalTrials.gov's posted results, through CTTI's AACT",
"license": "ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299",
"notice": "ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.",
"short": "Freely available. Acknowledgement requested"
},
{
"source": "ChEMBL, through Open Targets",
"license": "CC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence",
"notice": null,
"short": "CC BY-SA 3.0"
},
{
"source": "ClinicalTrials.gov",
"license": "none stated",
"notice": "ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.",
"short": "None stated"
},
{
"source": "EMBL-EBI's patent proteins",
"license": "EMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: \"EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners\" and \"EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools.\" Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use",
"notice": null,
"short": "No added restrictions. Attribution expected"
},
{
"source": "GenBank's patent files",
"license": "GenBank's patent files. NCBI: \"NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted.\" Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/",
"notice": null,
"short": "No restrictions from NCBI. Submitters may hold rights"
},
{
"source": "HGNC",
"license": "CC0: https://www.genenames.org/about/license/",
"notice": null,
"short": "CC0"
},
{
"source": "NCBI Gene",
"license": "None named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/",
"notice": null,
"short": "None named. Public domain as US government information"
},
{
"source": "NIH's project files and grant-paper links",
"license": "Public domain (NIH RePORTER)",
"notice": null,
"short": "Public domain"
},
{
"source": "Open Targets",
"license": "CC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence",
"notice": null,
"short": "CC0 1.0"
},
{
"source": "PubTator 3",
"license": "Public domain",
"notice": null,
"short": "Public domain"
},
{
"source": "UniProt",
"license": "CC BY 4.0. UniProt's licence file: \"All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy.\" UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license",
"notice": null,
"short": "CC BY 4.0"
}
],
"next": "/api/genes/v1?page=5",
"request_id": "-icsutjt0lJ_qKxs"
}ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
ClinicalTrials.gov
Search clinical trials by condition, drug, outcome or NCT number, with the results each one posted.
ClinicalTrials.gov
Comparisons of the groups of clinical trials, such as a risk ratio or a number needed to treat, calculated from the counts each trial posted.
Patent publications
Paste a sequence and see the patents that disclose it.
For invited accounts.
Opens sequences.conductscience.org
For software
Every answer on this page is also JSON, under /api/genes/v1. No key.
GET https://conductscience.org/api/genes/v1?q=p53
Ask an assistant